Pharming Group Nv
General ticker "PHAR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $424.9M
Pharming Group Nv does not follow the US Stock Market performance with the rate: -34.4%.
Estimated limits based on current volatility of 5.6%: low 8.97$, high 10.03$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [5.82$, 12.30$]
- 2024-12-30 to 2025-12-30 estimated range: [4.87$, 10.33$]
Financial Metrics affecting the PHAR estimates:
- Negative: Non-GAAP EPS, $ of -0.13 <= 0.10
- Negative: Operating profit margin, % of -1.95 <= 1.03
- Positive: -3.48 < Investing cash flow per share, $ of -1.97
- Negative: Operating cash flow per share per price, % of -2.23 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0.09 <= 0.14
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term PHAR quotes
Long-term PHAR plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 |
|---|---|---|
| Operating Revenue | $205.62MM | $245.32MM |
| Operating Expenses | $187.39MM | $250.20MM |
| Operating Income | $18.23MM | $-4.88MM |
| Non-Operating Income | $-3.25MM | $-7.13MM |
| Interest Expense | $5.36MM | $5.96MM |
| R&D Expense | $52.53MM | $68.91MM |
| Income(Loss) | $14.99MM | $-12.01MM |
| Taxes | $1.31MM | $-1.46MM |
| Profit(Loss) | $13.67MM | $-10.55MM |
| Stockholders Equity | $204.64MM | $218.78MM |
| Inventory | $42.33MM | $56.76MM |
| Assets | $425.80MM | $462.85MM |
| Operating Cash Flow | $22.90MM | $-17.30MM |
| Capital expenditure | $1.98MM | $1.46MM |
| Investing Cash Flow | $5.32MM | $-129.39MM |
| Financing Cash Flow | $-4.98MM | $-0.94MM |
| Earnings Per Share* | $0.21 | $-0.01 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.